CoChat

Acarbose in NIDDM Patients With Poor Control on Conventional Oral Agents: A 24-week placebo-controlled study

Lam, Karen SL, Tiu, SC, Tsang, MW, Ip, TP, Tam, Sidney CF · 1998 · Diabetes Care
Cited by 56

The DOI matches its Crossref record.

Abstract

OBJECTIVE: To determine the efficacy of acarbose, compared with placebo, on the metabolic control of NIDDM patients inadequately controlled on maximal doses of conventional oral agents. RESEARCH DESIGN AND METHODS: In this three-center double-blind study, 90 Chinese NIDDM patients with persistent poor glycemic control despite maximal doses of sulfonylurea and metformin were randomly assigned to receive additional treatment with acarbose 100 mg thrice daily or placebo for 24 weeks, after 6 weeks of dietary reinforcement. Efficacy was assessed by changes in HbA1c, fasting and 1-h postprandial plasma glucose and insulin levels, and fasting lipid levels. RESULTS: Acarbose treatment was associated with significantly greater reductions in HbA1c (−0.5 ± 0.2% vs. placebo 0.1 ± 0.2% [means ± SEM], P = 0.038), 1-h postprandial glucose (−2.3 ± 0.4 mmol/1 vs. placebo 0.7 ± 0.4 mmol/1, P < 0.001) and body weight (−0.54 ± 0.32 kg vs. placebo 0.42 ± 0.29 kg, P < 0.05). There was no significant difference between the two groups regarding changes in fasting plasma glucose and lipids or fasting and postprandial insulin levels. Flatulence was the most common side effect (acarbose vs. placebo: 28/45 vs. 11/44, P < 0.05). One patient on acarbose had asymptomatic elevations in serum transaminases that normalized in 4 weeks after acarbose withdrawal. Another patient on acarbose developed severe hypoglycemia; glycemic control was subsequently maintained on half the baseline dosage of sulfonylurea. CONCLUSIONS: In NIDDM patients inadequately controlled on conventional oral agents, acarbose in moderate doses resulted in beneficial effects on glycemic control, especially postprandial glycemia, and mean body weight. Additional use of acarbose can be considered as a useful alternative in such patients if they are reluctant to accept insulin therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/diacare.21.7.1154

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 56

Metadata

Authors
Lam, K. S., Tiu, S., Tsang, M., Ip, T., & Tam, S. C.
Venue
Diabetes Care
Published
1998-07-01
Volume
21
Issue
7
Pages
1154-1158
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2115720674
Cited by
56
References
0
FWCI
1.63
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Acarbose in NIDDM Patients With Poor Control on Conventional Oral Agents: A 24-week placebo-controlled study. https://app.cochat.ai/papers/10.2337/diacare.21.7.1154
The paper
Lam, K. S., Tiu, S., Tsang, M., Ip, T., & Tam, S. C. (1998). Acarbose in NIDDM Patients With Poor Control on Conventional Oral Agents: A 24-week placebo-controlled study. Diabetes Care. https://doi.org/10.2337/diacare.21.7.1154

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.